DiscoverPCR PerspectivesFirst guidelines for the treatment of LM disease issued by SOLACI and SIAC
First guidelines for the treatment of LM disease issued by SOLACI and SIAC

First guidelines for the treatment of LM disease issued by SOLACI and SIAC

Update: 2025-08-14
Share

Description

Cleverson Zukowski and Pablo Lamelas take a moment during #europcr 2025 to shed light on a major regional milestone: the first-ever guidelines for the treatment of left main disease, issued jointly by the Latin American Society of Interventional Cardiology (SOLACI) and the Interamerican Society of Cardiology (SIAC).


Why were these guidelines created specifically for Latin America? What are their key recommendations? And how can they be applied in day-to-day practice, especially when deciding between PCI and surgery?


Tune in to hear how these guidelines reflect the region’s unique healthcare challenges and may help tailor treatment to the specific needs of Latin American patients.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

First guidelines for the treatment of LM disease issued by SOLACI and SIAC

First guidelines for the treatment of LM disease issued by SOLACI and SIAC